Using Histopathologic Evidence to Differentiate Reproductive Senescence from Xenobiotic Effects in Middle-aged Female

Norimitsu Shirai1, Christopher Houle2, Michael L Mirsky2

  • 1Pfizer Inc., Groton, Connecticut, USA norimitsu.shirai@pfizer.com.

Toxicologic Pathology
|July 30, 2015
PubMed

Related Concept Videos